Etiologic agents of otitis media in Benin City, Nigeria

North American Journal of Medical Sciences

Volumn 3, Issue 2, 2011, Pages 95-98

  Osazuwa, Favour ^a   Osazuwa, Emmanuel ^a   Osime, Clement ^a   Igharo, Esohe Amanda ^a   Imade, Paul Erhumwunse ^a   Lofor, Patrick ^a   Momoh, Moses ^a   Omoregie, Richard ^a   Dirisu, John ^a  

^a UNIVERSITY OF BENIN   (Nigeria)

Author keywords

Benin City; Etiologic agents; Otitis media; Prevalence

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFUROXIME; ERYTHROMYCIN; GENTAMICIN; LINCOMYCIN; OFLOXACIN; OXACILLIN; TETRACYCLINE;

ADOLESCENT; ADULT; AGED; ALCALIGENES; ANTIBIOTIC SENSITIVITY; ARTICLE; ASPERGILLUS FLAVUS; ASPERGILLUS NIGER; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CHILD; CITROBACTER FREUNDII; CONTROLLED STUDY; CULTURE MEDIUM; EAR DISEASE; ESCHERICHIA COLI; FEMALE; FUNGUS ISOLATION; HUMAN; INFANT; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; MYCOLOGY; NIGERIA; OTITIS MEDIA; PATHOGENESIS; PROTEUS; PSEUDOMONAS AERUGINOSA; SCHOOL CHILD; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 79952605206     PISSN: None     EISSN: 19472714     Source Type: Journal    
DOI: 10.4297/najms.2011.395     Document Type: Article

References (21)

1. Ifante-Rivard C, Fernandez A. Otitis Media in Children: Frequency, Risk factors and research avenues. Epidemiol Rev 1993; 15: 446-65.
2. Arroll B. Antibiotics for upper respiratory tract infections. "An Overview of Cochrane Reviews" Med 2005; 3: 255-261.
3. Li WC, Chiu NC, HSU CH, Lee KS, Hwang HK, Huang-Fu. Pathogens in the middle ear effusion of children with persistent otitis media: Implications of drug resistance and complications. J Microbiol Immunol Infect 2001; 34: 190-194.
4. Weiner R, Collison PJ. Middle Ear pathogens in Otitis prone children, South Dakota J Med 2003; 56: 103-107.
5. Aich ML, Biswas AC, Ahmed M, Joarder MAH, Datta PG, Alauddin M. Prevalence of Otitis media with effusion among school going children in Bangladesh. Bangladesh J Otorhinolaryngol 2009; 15: 31-34.
6. Bluestone CD. Otitis media; to treat or not to treat. Consultant 1998:1421-1433.
7. Block SL. Causative Pathogens, antibiotic resistance and Therapeutic Considerations in Otitis media. Paediatr Infect Dis J 1997; 16: 449-456.
8. Minja BM, Machemba A. Prevalence of Otitis media, hearing impairment and cerumen impaction among school children in rural and urban Dar es Salam, Tanzania. Int J Pediatr Otorhinolaryngol 1996; 37: 29-34.
9. National population commission. Census figures 2006, National population commission, FCT Abuja.
10. Cowan ST, Steel KJ. Manual for the Identification of Medical Bacteria. 2nd edn. Cambridge University press, Cambridge, 1974.
11. National Committee for Clinical Laboratory Standards. Approved Standard M2-A5 for antibacterial disc susceptibility test. Villanova, 1993.
12. Collins CH, Lyne PH. Microbiological Methods 5th Ed. Butterworth and Co-publisher Ltd. Ibadan, 2000.
13. Yehia MM, Habib HM, Shehab NM. Ear infections J Laryngol Otol 1990; 104: 387-389.
14. Egbe CA, Mordi R, Omoregie R, Enabulele O. Prevalence of Otitis media in Okada Community, Edo State, Nigeria. Macedonian J. Med. Sci. 2010; 3(3): 299-302.
15. Parry D, Roland D. Middle Ear Chronic Suppurative otitis media. Medical treatment 2002 pp. 12-15.
16. Nwabuisi C, Ologe FE. Pathogenic agents of chronic suppurative otitis media in Ilorin, Nigeria. East Afr Med J 2002; 79(4): 202-205.
17. Brook I, Gober AE. Microbiological Characteristic of Persistent otitis media. Arch Otolaryngol 1998; 124: 1350-1352.
18. Bluestone CD, Stephenson JS, Martin LM. Ten-year review of Otitis media pathogens. Paediatr infect Dis J 1992; 11: 57-11.
19. Gugnai HC, Okafor BC, Nzeilb F, Njoku-Obian M. Aetiological agent of Otomycosis in Nigeria. Mycoses 1989; 32(5): 224-229.
20. Omoregie R, Eghafona NO. Urinary Tract Infection among Asymptomatic HIV patients in Benin City, Nigeria. Br J Biomed sci 2009; 66: 190-193.
21. Okeke IN, Lamikara A, Edelman R. Socio-economic and behavioural Factors leading to acquired bacterial resistance to antibiotics in developing countries. Emerg Infect Dis 1999; 5: 18-27.